RIDAURA (Sebela Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the RIDAURA drug offered from Sebela Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sebela Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | auranofin |
| SUBSTANCE NAME: | AURANOFIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-12-15 |
| END MARKETING DATE: | 0000-00-00 |
RIDAURA HUMAN PRESCRIPTION DRUG Details:
| Item Description | RIDAURA from Sebela Pharmaceuticals Inc. |
| LABELER NAME: | Sebela Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3(mg/1) |
| START MARKETING DATE: | 2016-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54766-093_43ba3de1-ab2f-06f6-e054-00144ff8d46c |
| PRODUCT NDC: | 54766-093 |
| APPLICATION NUMBER: | NDA018689 |
Other AURANOFIN Pharmaceutical Manufacturers / Labelers:
